Isoray - Treating Prostate Cancer with Brachytherapy
  • Patients
    • Patients
    • Why Brachytherapy?
    • Why Cesium-131?
    • Treatment Areas
      • Prostate
      • Brain
      • Gynecological
      • Head & Neck
      • Lung
    • Cesium Pioneers
    • Find a Doctor
    • Terms and Abbreviations
  • Clinicians
    • Clinicians
    • Cesium Pioneers
    • Why Brachytherapy?
    • Why Cesium-131?
    • Products
    • Conferences
  • About
    • About
      • Quality and Regulatory
    • Contact Isoray
    • News
    • Videos
    • Careers
    • Management Team
    • Events
    • Investors
      • Press Releases
      • ISR on NYSE
      • SEC Filings
      • Presentations
      • FAQ
      • Investor Contact
  • Find A Doctor
Select Page
Transitioning isotopes for prostate brachytherapy: Dr. Bernard Taylor, Texas Oncology

Transitioning isotopes for prostate brachytherapy: Dr. Bernard Taylor, Texas Oncology

Transition concerns should not stop you from adding Cesium to your prostate brachytherapy practice. With a thoughtful approach to planning and the right support, you can seamlessly upgrade your prostate brachytherapy to the power of Cesium. Dr. Bernard Taylor has...

Prostate Cancer Research Institute: “The Importance of Knowing About All of Your Prostate Cancer Treatment Options”

“I urge newly diagnosed men to see a range of specialists before selecting treatment. After talking to a urologist, they should make independent appointments with a radiation oncologist, a medical oncologist, and a brachytherapist to ensure that they become fully...
Advantageous biological effect, Cesium-131’s short half-life, and new shielded or dynamically modulated sources: Dr. Mark Rivard’s thoughts on brachytherapy from ABS 2018

Advantageous biological effect, Cesium-131’s short half-life, and new shielded or dynamically modulated sources: Dr. Mark Rivard’s thoughts on brachytherapy from ABS 2018

As a physicist, Dr. Mark Rivard is fascinated by brachytherapy’s ability to provide “conformal, localized” radiotherapy compared to external-beam radiation therapy for treatment of multiple cancer types. He was kind enough to share his thoughts with us in a video...
ASTRO 2018 Insights: building community, innovating and celebrating strong data around the power of Cesium

ASTRO 2018 Insights: building community, innovating and celebrating strong data around the power of Cesium

Building community around the power of Cesium The radiation oncologist community is one of the cornerstones on which we are building the future of brachytherapy at Isoray. As such, in person engagements at the ASTRO Annual Meeting are some of our most important...
Study Shows Significantly Improved Survival Rate of Cervical Cancer Patients after Receiving Brachytherapy and EBRT

Study Shows Significantly Improved Survival Rate of Cervical Cancer Patients after Receiving Brachytherapy and EBRT

The International Journal of Radiation Oncology recently published a study titled Survival Benefit of Adjuvant Brachytherapy After Hysterectomy With Positive Surgical Margins in Cervical Cancer. This study aimed to evaluate the effects on survival rate in patients...
Nearly out of treatment options, Cesium-131 brachytherapy saved Barbara’s life

Nearly out of treatment options, Cesium-131 brachytherapy saved Barbara’s life

Barbara Touchstone first survived cervical cancer following a radical hysterectomy, radiation and chemotherapy. In spite of the debilitating rigor of her initial course of treatment, the cancer returned in 2015. As a 35-year-old nurse and mother, she had reached the...
« Older Entries

Categories

  • Blog
  • Isoray News
  • Other
  • Physician Spotlight
  • Press Release
  • Prostate Cancer Awareness Month
  • Prostate News
  • Quarterly Results
  • Study
  • Surgeon Spotlight
  • Uncategorized
  • Patients
  • Clinicians
  • Cesium Pioneers
  • Why Brachytherapy?
  • Why Cesium-131?
  • About
  • Contact
  • News
  • Careers
  • Investors

About

Isoray passionately designs and develops innovative and personalized brachytherapy products that effectively treat many forms of cancer. We believe in pioneering solutions for life beyond your cancer.
  • Home
  • About
  • Contact
  • Terms of Use
  • Privacy Policy
  • Facebook
  • Twitter
  • RSS
Copyright 2019 Isoray Inc.
Disclosure: The physicians featured on this website may have prior or current relationships with IsoRay. These relationships may include, for example: membership on IsoRay’s Advisory Board; participation as a clinical investigator in research conducted on IsoRay products; provision of consultation or training services; or engagement as a prospective partner in the development of new products. Many of these physicians have received or continue to receive compensation from IsoRay in one form or another. The principal nature of a specific physician’s relationship is disclosed on this website adjacent to language featuring that physician.